Inteum Company
Links
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - anti-infective
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Anti-bacterial Treatments Using Peptide-Based Inhibitors of the STAT3-IL10 Pathway
Abstract: Tuberculosis (TB) is an infectious disease that typically affects the lungs. Current therapies include a panel of antibiotics given over a range of 6-9 months. As a result of the expense of treatment, the extended timeframe needed for effective treatment, and the scarcity of medicines in some developing countries, patient compliance with TB...
Published: 4/22/2025
|
Inventor(s):
Nadya Tarasova
,
Mercedes Gonzalez-Juarreto
Keywords(s):
Anti-infective
,
IL-10
,
immunomodulatory
,
Immunotherapy
,
INTERLEUKIN
,
STAT3
,
TUBERCULOSIS
Category(s):
Application > Therapeutics
,
Collaboration Sought > Licensing
,
Collaboration Sought > Collaboration
,
TherapeuticArea > Immunology
,
TherapeuticArea > Infectious Disease
Potent and Selective Cyclic Peptide Inhibitors of Phosphoglycerate Mutase as
Anti-Infective
Agents
Summary – The invention includes compounds and compositions for inhibiting phosphoglycerate mutase (PGM) activity. In some examples, the compounds selectively inhibit cofactor-independent PGM (iPGM). In particular embodiments, the compounds include one or more cyclic peptides. Brief Background – Co-factor independent phosphoglycerate mutase (iPGM)...
Published: 10/28/2024
|
Inventor(s):
Patricia Dranchak
,
Ryan Macarthur
,
James Inglese
Keywords(s):
Agents
,
Anti-infective
,
Cyclic
,
DB2XXX
,
DB3XXX
,
Inhibitors
,
Mutase
,
Peptide
,
Phosphoglycerate
,
POTENT
,
SELECTIVE
,
VJXXXX
,
VQXXXX
Category(s):
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
,
TherapeuticArea > Infectious Disease
,
Application > Therapeutics
Antibacterial activity of natural compounds and their synthetic analogue: A potential new antibiotic with potent activity against multiple drug resistant bacterial pathogens
Our researchers have developed novel compounds that are potential new
anti-infective
therapeutics useful for treatment against the deadly bacteria MRSA (methicillin-resistant Staphylococcus aureus), VRE (vancomycin-resistant Enterococcus faecium), and several other well-known common infectious agents.Background & Unmet Need:Before antibiotics became...
Published: 8/9/2022
|
Inventor(s):
Hossein Salimnia
,
Fazlul Sarkar
,
Subhash Padhye
,
Bernhard Biersack
Keywords(s):
Analog or Analogue
,
Antibiotics
,
Anti-infective
,
Anti-microbial
,
Disease
Category(s):
Biologicals
,
Diseases
,
Infectious disease
,
Life Science
,
Therapeutics